Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Midazolam oral - Primex Pharmaceuticals

Next Previous
X
Search
Drug Profile

Midazolam oral - Primex Pharmaceuticals

Alternative Names: ADV 6209; Ozalin

Latest Information Update: 31 Dec 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Advicenne
  • Developer Primex Pharmaceuticals
  • Class 3-ring heterocyclic compounds; Antiepileptic drugs; Benzodiazepines; Chlorinated hydrocarbons; Fluorobenzenes; Hypnosedatives; Imidazoles; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Anaesthesia; Sedation

Most Recent Events

  • 03 Mar 2020 Registered (via decentralised procedure) for Anaesthesia (In adolescents, In children, In infants) in Germany, Austria, Spain, Portugal, Ireland, Belgium, Greece, Poland (PO)
  • 03 Mar 2020 Registered (via decentralised procedure) for Sedation (In adolescents, In children, In infants) in Poland, Greece, Belgium, Ireland, Portugal, Spain, Austria, Germany (PO)
  • 10 Sep 2019 Launched for Anaesthesia (In adolescents, In children, In infants) in United Kingdom (PO) prior to September 2019 - First global launch

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top